The reduced liver fibrosis that we observed in NprcAKO mice is reminiscent of previous findings that continuous ANP intravenous infusion or transgenic BNP overexpression prevents liver fibrosis (48, 49). This evidence concerns the gene NPPB and Hepatic fibrosis.